SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,823 | +47.5% | 116 | 0.0% | 0.00% | – |
| Q2 2022 | $8,695 | -4.0% | 116 | 0.0% | 0.00% | – |
| Q1 2022 | $9,062 | -13.2% | 116 | 0.0% | 0.00% | – |
| Q4 2021 | $10,446 | -2.6% | 116 | 0.0% | 0.00% | – |
| Q3 2021 | $10,728 | -51.7% | 116 | -59.4% | 0.00% | -100.0% |
| Q2 2021 | $22,234 | -19.2% | 286 | -22.5% | 0.00% | 0.0% |
| Q1 2021 | $27,502 | -55.2% | 369 | +2.5% | 0.00% | -66.7% |
| Q4 2020 | $61,376 | +22.1% | 360 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $50,274 | +60.0% | 358 | +82.7% | 0.00% | +50.0% |
| Q2 2020 | $31,427 | +63.9% | 196 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $19,173 | -27.9% | 196 | -4.9% | 0.00% | 0.0% |
| Q4 2019 | $26,582 | +2.5% | 206 | -41.1% | 0.00% | -50.0% |
| Q1 2018 | $25,932 | +55.4% | 350 | +16.7% | 0.00% | +33.3% |
| Q4 2017 | $16,692 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |